{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:29:22Z","timestamp":1777530562725,"version":"3.51.4"},"reference-count":29,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T00:00:00Z","timestamp":1558828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["U01 HL081649"],"award-info":[{"award-number":["U01 HL081649"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cardiovasc Pharmacol Ther"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Lipoprotein-associated phospholipase A\n                      <jats:sub>2<\/jats:sub>\n                      (LpPLA\n                      <jats:sub>2<\/jats:sub>\n                      ) is an inflammatory marker that has been associated with the presence of vulnerable plaque and increased risk of cardiovascular (CV) events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      To assess the effect of extended-release niacin (ERN) on Lp-PLA\n                      <jats:sub>2<\/jats:sub>\n                      activity and clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We performed a post hoc analysis in 3196 AIM-HIGH patients with established CV disease and low baseline levels of high-density lipoprotein cholesterol (HDL-C) who were randomized to ERN versus placebo on a background of simvastatin therapy (with or without ezetimibe) to assess the association between baseline Lp-PLA\n                      <jats:sub>2<\/jats:sub>\n                      activity and the rate of the composite primary end point (CV death, myocardial infarction, stroke, hospitalization for unstable angina, and symptom-driven revascularization).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Participants randomized to ERN, but not those randomized to placebo, experienced a significant 8.9% decrease in LpPLA\n                      <jats:sub>2<\/jats:sub>\n                      . In univariate analysis, the highest quartile of LpPLA\n                      <jats:sub>2<\/jats:sub>\n                      activity (&gt;208 nmol\/min\/mL, Q4) was associated with higher event rates compared to the lower quartiles in the placebo group (log rank P = .032), but not in the ERN treated participants (log rank P = .718). However, in multivariate analysis, adjusting for sex, diabetes, baseline LDL-C, HDL-C, and triglycerides, there was no significant difference in outcomes between the highest Lp-PLA2 activity quartile versus the lower quartiles in both the placebo and the ERN groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      Among participants with stable CV disease on optimal medical therapy, elevated Lp-PLA\n                      <jats:sub>2<\/jats:sub>\n                      was associated with higher CV events; however, addition of ERN mitigates this effect. This association in the placebo group was attenuated after multivariable adjustment, which suggests that Lp-PLA\n                      <jats:sub>2<\/jats:sub>\n                      does not improve risk assessment beyond traditional risk factors.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1074248419852955","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T01:11:32Z","timestamp":1558919492000},"page":"534-541","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Extended-Release Niacin on Quartile Lp-PLA\n                    <sub>2<\/sub>\n                    Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial"],"prefix":"10.1177","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-7602","authenticated-orcid":false,"given":"Radmila","family":"Lyubarova","sequence":"first","affiliation":[{"name":"Division of Cardiology, Albany Medical Center, Albany Medical College, Albany, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Albers","sequence":"additional","affiliation":[{"name":"University of Washington, Northwest Lipid Metabolism, And Diabetes Research Laboratories, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santica M.","family":"Marcovina","sequence":"additional","affiliation":[{"name":"University of Washington, Northwest Lipid Metabolism, And Diabetes Research Laboratories, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[{"name":"Axio Research LLC, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"McBride","sequence":"additional","affiliation":[{"name":"Axio Research LLC, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Topliceanu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Albany Medical Center, Albany Medical College, Albany, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Anderson","sequence":"additional","affiliation":[{"name":"University of Calgary and Libin Cardiovascular Institute, Foothills Medical Centre, Calgary, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome L.","family":"Fleg","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Desvigne-Nickens","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moti L.","family":"Kashyap","sequence":"additional","affiliation":[{"name":"VA Long Beach Healthcare System, Long Beach, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"McGovern","sequence":"additional","affiliation":[{"name":"Miami Beach, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Boden","sequence":"additional","affiliation":[{"name":"New England Healthcare System, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,5,26]]},"reference":[{"key":"bibr1-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.04.019"},{"key":"bibr2-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000160551.21962.a7"},{"key":"bibr3-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.05.001"},{"issue":"2","key":"bibr4-1074248419852955","first-page":"299","volume":"177","author":"Benitez S","year":"2004","journal-title":"Atherosclerosis"},{"key":"bibr5-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-011-0063-4"},{"key":"bibr6-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.180281"},{"key":"bibr7-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431603"},{"key":"bibr8-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116763.91992.F1"},{"key":"bibr9-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000154553.12214.CD"},{"key":"bibr10-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.09.021"},{"key":"bibr11-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi010"},{"issue":"14","key":"bibr12-1074248419852955","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/CIRCULATIONAHA.105.612630","volume":"113","author":"O\u2019Donoghue M","year":"2006","journal-title":"Circulation"},{"key":"bibr13-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.151670"},{"key":"bibr14-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000222983.73369.c8"},{"key":"bibr15-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)60992-0"},{"key":"bibr16-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60319-4"},{"key":"bibr17-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.07.005"},{"key":"bibr18-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.771899"},{"issue":"17","key":"bibr19-1074248419852955","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jacc.2007.11.079","volume":"51","author":"Mohler ER III","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"bibr20-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315878"},{"key":"bibr21-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.11061"},{"issue":"3","key":"bibr22-1074248419852955","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ahj.2010.11.017","volume":"161","author":"The AIM-HIGH Investigators","year":"2011","journal-title":"Am Heart J"},{"key":"bibr23-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107579"},{"key":"bibr24-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.04.044"},{"key":"bibr25-1074248419852955","volume-title":"Clinical lipidology: a companion to Braunwald\u2019s heart disease","author":"Ballantyne C","year":"2015","edition":"2"},{"key":"bibr26-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.023"},{"key":"bibr27-1074248419852955","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.093468"},{"key":"bibr28-1074248419852955","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.154512"},{"key":"bibr29-1074248419852955","volume":"2018","author":"Grundy SM","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiovascular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1074248419852955","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1074248419852955","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1074248419852955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:43:03Z","timestamp":1777394583000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1074248419852955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,26]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1177\/1074248419852955"],"URL":"https:\/\/doi.org\/10.1177\/1074248419852955","relation":{},"ISSN":["1074-2484","1940-4034"],"issn-type":[{"value":"1074-2484","type":"print"},{"value":"1940-4034","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,26]]}}}